From the blog

Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma

Published: August 19, 2022

Primary Outcome Measures

  1. disease free survival or time to recurrence [ Time Frame: Through out the whole study with maximum of 2 years ]
    time from clearance of disease till onset of recurrence of same disease
  2. overall survival [ Time Frame: till mortality of the case or 2 years maximum ]
    survival of the cases till mortality

Secondary Outcome Measures

  1. comorbidities [ Time Frame: Through out the whole study duration with maximum of two years ]
    complications that may encounter either pre , intra or post intervention

Inclusion Criteria

  • patients presented with localised MPM are the main target and histopathological diagnosis of MPM is made via video-assisted thoracoscopic surgery or open multiple pleural biopsies.

Exclusion Criteria

  • patients with stage III or IV MPM in which cytoreductive surgery has no role.
  • Patients underwent extrapleural pneumonectomy (EPP) as a cytoreductive surgery , because we are focusing on P/D only either conventional P/D or extended P/D
Contact Us
Have you received a diagnosis? *